Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders — Therapeutic potential or a mirage?
Authors:
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 31 (7) , 1347-1355
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning paradigmNeurobiology of Learning and Memory, 2006
- Colostrinin-Driven Neurite Outgrowth Requires p53 Activation in PC12 CellsCellular and Molecular Neurobiology, 2005
- Studies on the mechanism of action of a proline-rich polypeptide complex (PRP): Effect on the stage of cell differentiationPeptides, 2005
- A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in miceRegulatory Peptides, 2005
- Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s DiseaseDrugs & Aging, 2003
- Immunoregulation of microglial functional propertiesMicroscopy Research and Technique, 2001
- α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γBiochemical and Biophysical Research Communications, 1999
- Immunoregulatory properties of synthetic peptides, fragments of a proline-rich polypeptide (PRP) from ovine colostrum☆Molecular Immunology, 1987
- Immunologically active nonapeptide fragment of a proline-rich polypeptide from ovine colostrum: Amino acid sequence and immunoregulatory propertiesMolecular Immunology, 1983
- Isolation and characterization of a proline‐rich polypeptide from ovine colostrumFEBS Letters, 1974